NAV: 28 Mar 2024 | ₹17.17 |
Min. SIP amount | Not Supported |
Rating | 2 |
Fund size | ₹141.53Cr |
6M | 1Y | 3Y | All | |
---|---|---|---|---|
Fund returns | NA | 46.3% | 16.4% | 17.1% |
Category average | NA | 57.3% | 17.8% | NA |
Rank with in category | NA | 17 | 9 | NA |
Name | Sector | Instrument | Assets |
---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 14.43% |
Cipla Ltd. | Healthcare | Equity | 7.44% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 7.11% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.98% |
Max Healthcare Institute Ltd. | Healthcare | Equity | 5.82% |
Eli Lilly And Co | Healthcare | Forgn. Eq | 5.11% |
Divi's Laboratories Ltd. | Healthcare | Equity | 4.04% |
Lupin Ltd. | Healthcare | Equity | 3.46% |
Johnson & Johnson Ltd. | Healthcare | Forgn. Eq | 3.26% |
Merck & Co Inc (US) | Healthcare | Forgn. Eq | 2.71% |
Inclusive of GST
Nil
0.005% (from July 1st, 2020)
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
Min. for 1st investment | Not Supported |
Min. for 2nd investment onwards | Not Supported |
Min. for SIP | Not Supported |